Cargando…
Genetic re-direction of canine primary T cells for clinical trial use in pet dogs with spontaneous cancer
Immunocompetent pet dogs develop spontaneous, human-like cancers, representing a parallel patient population for the investigation of chimeric antigen receptor (CAR) therapies. We have optimized a retrovirus-based protocol to efficiently CAR transduce primary T cells from healthy and tumor-bearing d...
Autores principales: | Rotolo, Antonia, Atherton, Matthew J., Kasper, Brian T., Haran, Kumudhini P., Mason, Nicola J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551231/ https://www.ncbi.nlm.nih.gov/pubmed/34746864 http://dx.doi.org/10.1016/j.xpro.2021.100905 |
Ejemplares similares
-
Case Report: Clinical and Serological Hallmarks of Cytokine Release Syndrome in a Canine B Cell Lymphoma Patient Treated With Autologous CAR-T Cells
por: Atherton, Matthew J., et al.
Publicado: (2022) -
Establishing a model system for evaluating CAR T cell therapy using dogs with spontaneous diffuse large B cell lymphoma
por: Panjwani, M. Kazim, et al.
Publicado: (2019) -
Development of a fully canine anti-canine CTLA4 monoclonal antibody for comparative translational research in dogs with spontaneous tumors
por: Mason, Nicola J., et al.
Publicado: (2021) -
Bite-size introduction to canine hematologic malignancies
por: Atherton, Matthew J., et al.
Publicado: (2022) -
Detection and genetic characterization of canine astroviruses in pet dogs in Guangxi, China
por: Zhou, Huabo, et al.
Publicado: (2017)